Literature DB >> 9498453

Antibody response to Chlamydia pneumoniae infection in children with respiratory illness.

A Kutlin1, P M Roblin, M R Hammerschlag.   

Abstract

Serologic diagnosis of Chlamydia pneumoniae infection has been based on the microimmunofluorescence test (MIF). However, recent prospective studies in children have found that >50% infected with C. pneumoniae failed to develop any antibodies detectable by MIF. In this study, single sera from 46 culture-positive and 42 culture-negative children with respiratory infection and known MIF status were examined by immunoblotting. Forty-one (89.1%) of the single sera from culture-positive and 27 (64.3%) from culture-negative children reacted to C. pneumoniae antigens in immunoblot. C. pneumoniae proteins most frequently recognized by sera from culture-positive patients were at 101-102, 72-76, 50-52, 48-49, 43-44, 41-42, and 30-31 kDa. However, there did not appear to be a correlation of specific band patterns and culture status.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9498453     DOI: 10.1086/514223

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  20 in total

Review 1.  Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies.

Authors:  Jens Boman; Margaret R Hammerschlag
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

2.  The Role of Chlamydia in Upper Respiratory Tract Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-04       Impact factor: 3.725

3.  Chlamydia pneumoniae serology: importance of methodology in patients with coronary heart disease and healthy individuals.

Authors:  A Schumacher; A B Lerkerød; I Seljeflot; L Sommervoll; I Holme; J E Otterstad; H Arnesen
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

4.  Current knowledge of Chlamydia pneumoniae and atherosclerosis.

Authors:  M R Hammerschlag
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-05       Impact factor: 3.267

5.  Identification of two novel genes encoding 97- to 99-kilodalton outer membrane proteins of Chlamydia pneumoniae.

Authors:  K Knudsen; A S Madsen; P Mygind; G Christiansen; S Birkelund
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

6.  Analysis of the humoral immune response to Chlamydia pneumoniae by immunoblotting and immunoprecipitation.

Authors:  A Essig; U Simnacher; M Susa; R Marre
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

7.  Prevalence of antibodies to Chlamydia pneumoniae in an Israeli population without clinical evidence of respiratory infection.

Authors:  M Ben-Yaakov; G Eshel; L Zaksonski; Z Lazarovich; I Boldur
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

8.  PCR detection and molecular identification of Chlamydiaceae species.

Authors:  J C Hartley; S Kaye; S Stevenson; J Bennett; G Ridgway
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

9.  Antibody response to chlamydiae in children with asthma and respiratory illness.

Authors:  J Kazár; E Kováčová; J Gašparovič; J Cervenka; K Furková; J Hornová; S Wimmerová
Journal:  Folia Microbiol (Praha)       Date:  2011-04-19       Impact factor: 2.099

10.  A novel synthetic peptide microarray assay detects Chlamydia species-specific antibodies in animal and human sera.

Authors:  Konrad Sachse; Kh Shamsur Rahman; Christiane Schnee; Elke Müller; Madlen Peisker; Thomas Schumacher; Evelyn Schubert; Anke Ruettger; Bernhard Kaltenboeck; Ralf Ehricht
Journal:  Sci Rep       Date:  2018-03-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.